Catalyst Wire Dossier Catalyst Wire Dossier

DHA/EPA-containing omega-3 supplement

docosahexaenoic acid and eicosapentaenoic acid
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DHA/EPA-containing omega-3 supplement, covering 2010-01-14 to 2010-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer [Phase 2, Phase 3]

See pricing